Mineralys Therapeutics, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 150 N. RADNOR CHESTER RD., RADNOR, PA, 19087
Mailing Address 150 N. RADNOR CHESTER RD., RADNOR, PA, 19087
Phone (888) 378-6240
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2024
-$177.81M
Net Income
$205.90M
Total Assets
$114.09M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 5, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | January 21, 2026 | View on SEC |
| 4 Insider stock transaction report | January 20, 2026 | View on SEC |
| 4 Insider stock transaction report | January 15, 2026 | View on SEC |
| 4 Insider stock transaction report | January 13, 2026 | View on SEC |
| 4 Insider stock transaction report | January 13, 2026 | View on SEC |
| 4 Insider stock transaction report | January 13, 2026 | View on SEC |
Insider Trading
STRONG SELL 4 insiders
18 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.